Abstract:Background: Early detection of pre-eclampsia (PE) has become one of the fundamental goals of perinatal medicine. Although clinical symptoms of PE emerge after the 20th week of gestation, trophoblast invasion that is responsible for pathogenesis occurs in the first trimester. This study aimed to evaluate the clinical utility of the Placental Growth Factor and uterine artery Doppler velocimetry in the evolution of preeclampsia. Methods: This was a cohort prospective study that was carried out on sixty pregnant women who were classified into 3 equal groups of pregnant women who had gestational age ranging from 20 to 26 weeks: the first group included pregnant women with normal pregnancy, the second group included pregnant women with mild preeclampsia, and the third group included cases with severe preeclampsia. Results: The mean of gestational age at delivery was significantly lower in patients who had severe preeclampsia than those with mild preeclampsia and controls. In contrast, there was no significant difference in the mean gestational age at delivery of patients with mild preeclampsia and controls. As for serum glutamic-oxaloacetic transaminase (SGOT), the concentration increased significantly in cases with severe preeclampsia compared to that of mild preeclampsia and controls. However, there were non-significance differences between controls and cases with mild preeclampsia. Receiver Operating Characteristic (ROC) curve showed that perfusion index (PI) had significantly higher diagnostic accuracy than other indices in predicting the outcome of the pregnancy and uterine artery pulsatility index had significantly higher diagnostic accuracy than both placental growth factor (PlGF) and uterine artery resistance index in predicting the severity of preeclampsia. Conclusions: Uterine artery Doppler screening is simple and non-invasive and there is a clear association of elevated mean uterine artery PI, respiratory index (RI), and also serum PlGF in the second trimester, with the occurrence of PE. Uterine artery pulsatility index (UAPI) was significantly associated with a high incidence of PE. The sensitivity or prediction is increased by adding serum marker PlGF and combinations provide an increase in the ability of prediction and determination compared to the tests used alone.

The performance of various serum parameters in blood during the first trimester in the early detection of pre-eclampsia

Expression of Matrix Metalloproteinase-2,-7,-9 in Serum During Pregnancy in Patients with Pre-Eclampsia: A Prospective Study

Routine ante-natal screening using maternal risk factors and biomarkers for preeclampsia in 11-13+6 weeks of gestation

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk

Study on the Level Changes of N-terminal Pro-B-type Natriuretic Peptide in the Serum of Patients with Pre-eclampsia and Its Clinical Significance

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study

Changes of serum cardiotropin I and cystatin C in preeclampsia and significance thereof

Changes of serum cardiotropin Ⅰ and cystatin C in preeclampsia and clinical significance thereof

Serum Adiponectin, Leptin and Soluble Leptin Receptor in Pre-Eclampsia.

Analyses of soluble endoglin and matrix metalloproteinase 14 using enzyme-linked immunosorbent assay in the diagnosis and assessment of severity of early- and late-onset pre-eclampsia

[Changes of serum cardiotrophin I and cystatin C in preeclampsia and clinical significance thereof].

Maternal Mid-Trimester Placental Growth Factor and Uterine Artery Doppler Velocimetry in Evolution of Pre-Eclampsia

Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study

Late first trimester circulating microparticle proteins predict the risk of preeclampsia < 35 weeks and suggest phenotypic differences among affected cases

Efficacy of serum markers and hemodynamic index of bilateral uterine arteries to predict preeclampsia in first trimester of pregnancy

Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study from a Center in Zhejiang Province, China

Could signal peptide complement C1r/C1s, Uegf, and Bmp1, and epidermal growth factor-containing protein 1 be a therapeutic target in the pathogenesis of preeclampsia?

First trimester complete blood cell indices in early and late onset preeclampsia

Identification of novel first-trimester serum biomarkers for early prediction of preeclampsia

Proteomic profile of preeclampsia in the first trimester of pregnancy